1.
Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data
2.
3.
Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data